BlackRock Investment Management’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$10.8M Sell
14,161
-1,115
-7% -$843K 0.01% 1072
2016
Q3
$12.5M Sell
15,276
-162
-1% -$140K 0.02% 863
2016
Q2
$12.9M Sell
15,438
-3,520
-19% -$2.94M 0.02% 804
2016
Q1
$17.4M Sell
18,958
-265
-1% -$253K 0.02% 636
2015
Q4
$19.8M Sell
19,223
-285
-1% -$286K 0.03% 578
2015
Q3
$18.4M Buy
+19,508
New +$20.3M 0.02% 598

Other funds holding AGN.PRA

BlackRock Investment Management's AGN.PRA Position: Q4 2016 in Review

BlackRock Investment Management reduced its Allergan plc (AGN.PRA) stake by 7.3% in Q4 2016, selling an estimated $843K and leaving 14,161 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1072.

BlackRock Investment Management first reported a position in AGN.PRA in Q3 2015 and has held it in 6 quarters since. The position peaked at $19.8M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

  • BlackRock Investment Management held 14,161 shares of Allergan plc worth $10.8M as of Q4 2016.
  • BlackRock Investment Management sold 1,115 Allergan plc shares in Q4 2016, an estimated $843K.
  • Allergan plc made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1072 holding.
  • BlackRock Investment Management first reported a position in Allergan plc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Investment Management's Allergan plc position peaked at $19.8M in Q4 2015.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.